# Doris Agneter

> Doris Agneter is a seed investor at tecnet equity (Sankt Pölten) backing Energy and Medical. See 8 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [tecnet equity](https://shizune.co/investors/profile/tecnet-equity)
- Location: Sankt Pölten, Austria
- Total investments: 8
- Last investment: Mar 2026
- Lead investor: 13%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/doris-agneter-46a9391

Doris Agneter is a seed investor at tecnet equity in Sankt Pölten focused on Energy and Medical. Doris Agneter is CEO of tecnet equity and in this role, its driving force, contributing a wealth of experience from top management positions in the banking and finance sector (including Raiffeisen Centrobank, RZB Private Equity Holding, Centro Property Holding AG, Austria Wirtschaftsservice). In her role as executive board member of RZB PE Holding,she worked closely with Austrian and international venture capital funds. In the course of her career, she has been a member of organisations such as AVCO, the Austrian Private Equity and Venture Capital Organisation, and expert groups of the European Commission. She holds a doctorate in technical mathematics from Vienna University of Technology as well as a post-graduate degree in business administration from the Institute for Advanced Studies (IHS), and is a lecturer at several Austrian universities.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Energy | 1 | 13% |
| Medical | 1 | 13% |
| Health Care | 1 | 13% |
| Biotechnology | 1 | 13% |
| Pharmaceutical | 1 | 13% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 25% |
| Series A | 1 | 13% |
| Venture - Series Unknown | 1 | 13% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| VALANX Biotech | VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development. | $3.5M | Venture - Series Unknown | Mar 12, 2026 |  |
| Sipfront | Sipfront is a Telco testing service for establishing SIP call scenarios towards your VoIP systems. | $2.1M | Seed | Jan 26, 2026 |  |
| Sipfront | Sipfront is a Telco testing service for establishing SIP call scenarios towards your VoIP systems. | $1.4M | Seed | Jan 30, 2024 |  |
| VALANX Biotech | VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development. | $2.5M | Seed | Nov 07, 2023 |  |
| Greenwood-Power | Greenwood-Power is a fast growing manufacturer and designer of non- conventional instrument transformers for the upcoming smart grid. We are focusing on medium voltage on secondary and primary energy distribution. Our products can fit into gas- and air-insulated switchgears and can be also used outdoor on poles. | $1.9M | Series A | Oct 15, 2022 |  |
| Greenwood-Power | Greenwood-Power is a fast growing manufacturer and designer of non- conventional instrument transformers for the upcoming smart grid. We are focusing on medium voltage on secondary and primary energy distribution. Our products can fit into gas- and air-insulated switchgears and can be also used outdoor on poles. | $1.8M | Series A | Aug 22, 2021 |  |
| Greenwood-Power | Greenwood-Power is a fast growing manufacturer and designer of non- conventional instrument transformers for the upcoming smart grid. We are focusing on medium voltage on secondary and primary energy distribution. Our products can fit into gas- and air-insulated switchgears and can be also used outdoor on poles. | $658.7K | Series A | May 26, 2020 |  |
| VALANX Biotech | VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development. |  | Seed | May 14, 2020 |  |

8 of 8 investments shown.

## Co-investors
- [XISTA Science Ventures](https://shizune.co/investors/profile/xista) — VC Fund, 5 deals together
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund, 4 deals together
- [eQventure](https://shizune.co/investors/profile/eqventure) — VC Fund, 3 deals together
- [xista science ventures](https://shizune.co/investors/profile/ist-cube) — VC Fund, 2 deals together
- [SkyGene](https://shizune.co/investors/profile/skygenext) — VC Fund, 2 deals together
- [Airbridge Equity Partners](https://shizune.co/investors/profile/airbridge-equity-partners) — VC Fund, 1 deal together

## About tecnet equity

VC Fund · Sankt Polten, Austria

tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.

5 contacts available at tecnet equity.

| Name | Title | Profile |
| --- | --- | --- |
| Christian Laurer | Senior Investment Manager | https://shizune.co/investors/profile/christian-laurer |
| Doris Agneter | Managing Director | https://shizune.co/investors/profile/doris-agneter |
| Juergen Milde-Ennoeckl | Investment Manager | https://shizune.co/investors/profile/jrgen-ennckl |
| Peter Buchinger | Investment Analyst | https://shizune.co/investors/profile/peter-buchinger |
| René Danzinger | Investment Manager | https://shizune.co/investors/profile/ren%C3%A9-danzinger |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Doris Agneter invest in?

Doris Agneter invests primarily in Energy, Medical and Health Care startups, most often at Seed and Series A stage. Most of the 8 investments tracked by Shizune back companies in Austria. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Doris Agneter last invest?

The most recent investment recorded for Doris Agneter closed in Mar 2026. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co